20 research outputs found
Lesion of the nipple-areola complex in patients with breast cancer
The article presents data about the lesion of the nipple-areola complex in breast cancer. In 2015-2016 surgical treatment was performed in 101 breast cancer patients, different in size but with the mandatory removal of the nipple-areola complex. There are analyzed the dependence of the lesion of the nipple-areola complex from histological types of breast cancer, molecular subtypes, multicentricity, the location of tumor in the breast. The most significant criterion was the dependence of the lesion of the nipple-areola complex from the distance between tumor node and the nipple
Lesion of the nipple-areola complex in patients with breast cancer
The article presents data about the lesion of the nipple-areola complex in breast cancer. In 2015-2016 surgical treatment was performed in 101 breast cancer patients, different in size but with the mandatory removal of the nipple-areola complex. There are analyzed the dependence of the lesion of the nipple-areola complex from histological types of breast cancer, molecular subtypes, multicentricity, the location of tumor in the breast. The most significant criterion was the dependence of the lesion of the nipple-areola complex from the distance between tumor node and the nipple
ΠΠ΅ΡΠ²ΠΈΡΠ½Π°Ρ ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΡΡΠ½Π°Ρ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ° ΠΏΠΎΡΠΊΠΈ. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ ΠΈ ΠΎΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
Primary thyroid-like follicular renal cell carcinoma is an extremely rare type of renal cell cancer with low malignancy potential and relatively good prognosis. It has not been included into the World Health Organization classification of renal tumors. This tumor is characterized by morphology similar to primary thyroid follicular cancer, but with different immune phenotype, which is important for morphological diagnosis. Surgery has been recognized as the only curative treatment. We describe our own observation of follicular renal carcinoma in a 68-year old man, in whom renal tumor was identified during his regular examination due to past colon cancer. The disease was asymptomatic. The patient had elective laparoscopic nephrectomy. At pathological assessment, the tumor looked like a follicular thyroid neoplasm. Immunohistochemistry revealed no expression of RCC, TTF-1, thyroglobulin, CD-10, synaptophysin, and chromogranin A. The differential diagnosis included metastatic primary thyroid malignancy as the most probable diagnosis, as well as highly differentiated neuroendocrine tumor and the so-called βthyroid kidneyβ that might occur in long-standing chronic pyelonephritis. Conclusion: The case of primary follicular renal carcinoma illustrates that this rare renal tumor is heterogeneous both in its structure and tumor cell immunophenotypes. Longer follow-up and accumulation of larger numbers of the disease is needed. This would allow for a more objective assessment of its prevalence in the population, of its clinical characteristics and morphological variability.ΠΠ΅ΡΠ²ΠΈΡΠ½Π°Ρ ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΡΡΠ½Π°Ρ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ° ΠΏΠΎΡΠΊΠΈ (Π°Π½Π³Π». primary thyroid-like follicular renal cell carcinoma) - ΡΡΠ΅Π·Π²ΡΡΠ°ΠΉΠ½ΠΎ ΡΠ΅Π΄ΠΊΠΈΠΉ Π²Π°ΡΠΈΠ°Π½Ρ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° Ρ Π½ΠΈΠ·ΠΊΠΈΠΌ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΠΎΠΌ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Ρ
ΠΎΡΠΎΡΠΈΠΌ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΎΠΌ, Π½Π΅ Π²ΠΊΠ»ΡΡΠ΅Π½ Π² ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΠΏΠΎΡΠΊΠΈ ΠΡΠ΅ΠΌΠΈΡΠ½ΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ. ΠΡΠ° ΠΎΠΏΡΡ
ΠΎΠ»Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΠ΅ΡΡΡ ΡΡ
ΠΎΠ΄Π½ΡΠΌ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΡΡΠΎΠ΅Π½ΠΈΠ΅ΠΌ Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΠΌ ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΡΡΠ½ΡΠΌ ΡΠ°ΠΊΠΎΠΌ ΡΠΈΡΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ, Π½ΠΎ ΠΎΡΠ»ΠΈΡΠ½ΡΠΌ ΠΎΡ Π½Π΅Π΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΎΠΌ, ΡΡΠΎ Π²Π°ΠΆΠ½ΠΎ Π΄Π»Ρ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. Π₯ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΠΏΡΠΈΠ·Π½Π°Π½ Π΅Π΄ΠΈΠ½ΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ°Π΄ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΠΏΠΈΡΠ°Π½ΠΎ ΡΠΎΠ±ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ ΠΏΠΎΡΠΊΠΈ Ρ ΠΌΡΠΆΡΠΈΠ½Ρ 68 Π»Π΅Ρ, Ρ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ ΠΏΡΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΌ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΡΠ°ΠΊΠ° ΡΠΎΠ»ΡΡΠΎΠΉ ΠΊΠΈΡΠΊΠΈ Π² Π°Π½Π°ΠΌΠ½Π΅Π·Π΅ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Π° ΠΎΠΏΡΡ
ΠΎΠ»Ρ ΠΏΠΎΡΠΊΠΈ. ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΠΊΠ°Π»ΠΎ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎ. Π ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠΌ ΠΏΠΎΡΡΠ΄ΠΊΠ΅ Π²ΡΠΏΠΎΠ»Π½Π΅Π½Π° Π»Π°ΠΏΠ°ΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠ°Ρ Π½Π΅ΡΡΡΠΊΡΠΎΠΌΠΈΡ. ΠΡΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΎΠ°Π½Π°ΡΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Ρ Π±ΡΠ»Π° ΠΏΠΎΡ
ΠΎΠΆΠ° Π½Π° ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΡΡΠ½ΡΡ ΠΎΠΏΡΡ
ΠΎΠ»Ρ ΡΠΈΡΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ. ΠΡΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ
ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΎΡΡΡΡΡΡΠ²ΠΎΠ²Π°Π»Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ RCC, TTF-1, ΡΠΈΡΠ΅ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π°, CD-10, ΡΠΈΠ½Π°ΠΏΡΠΎΡΠΈΠ·ΠΈΠ½Π°, Ρ
ΡΠΎΠΌΠΎΠ³ΡΠ°Π½ΠΈΠ½Π° Π. ΠΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ Π² ΠΏΠ΅ΡΠ²ΡΡ ΠΎΡΠ΅ΡΠ΅Π΄Ρ Ρ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠΌ ΠΎΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΡΠΈΡΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ, Ρ Π²ΡΡΠΎΠΊΠΎΠ΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π½Π΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ, Π° ΡΠ°ΠΊΠΆΠ΅ Ρ ΡΠ°ΠΊ Π½Π°Π·ΡΠ²Π°Π΅ΠΌΠΎΠΉ ΡΠΈΡΠ΅ΠΎΠΈΠ΄Π½ΠΎΠΉ ΠΏΠΎΡΠΊΠΎΠΉ, ΡΠ°Π·Π²ΠΈΠ²Π°ΡΡΠ΅ΠΉΡΡ ΠΏΡΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠΈ ΠΏΠΈΠ΅Π»ΠΎΠ½Π΅ΡΡΠΈΡΠ°. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ΅ Π½Π°ΠΌΠΈ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ ΠΏΠΎΡΠΊΠΈ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ ΡΡΠΎΡ ΡΠ΅Π΄ΠΊΠΈΠΉ Π²Π°ΡΠΈΠ°Π½Ρ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΏΠΎΡΠ΅ΠΊ Π½Π΅ΠΎΠ΄Π½ΠΎΡΠΎΠ΄Π΅Π½ ΠΈ ΠΏΠΎ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌ ΡΡΡΠΎΠ΅Π½ΠΈΡ, ΠΈ ΠΏΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ. ΠΠ΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ Π±ΠΎΠ»ΡΡΠ΅Π³ΠΎ ΡΠΈΡΠ»Π° ΡΠ»ΡΡΠ°Π΅Π² Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. ΠΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ Π±ΠΎΠ»Π΅Π΅ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ ΠΎΡΠ΅Π½ΠΈΡΡ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΡΡΠΈΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Π² ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ, ΠΈΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ ΠΈ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ Π²Π°ΡΠΈΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΡ
Π§ΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎ-ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΈΠ½Ρ ΡΠΎΠ½Π½ΠΎΠ³ΠΎ Π΄Π²ΡΡΡΠΎΡΠΎΠ½Π½Π΅Π³ΠΎ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΡΡ ΠΆΠ΅Π»Π΅Π· ΠΊ Π½Π΅ΠΎΠ°Π΄ΡΡΠ²Π°Π½ΡΠ½ΠΎΠΉ Ρ ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ
Objective β to evaluate the sensitivity of multiple primary bilateral synchronous breast cancer (BC) to neoadjuvant drug therapy. Subject and methods. The investigation enrolled 14 patients with multiple primary synchronous BC who received drug treatment at the first stage of combined treatment. Eleven patients underwent 6 to 8 cycles of neoadjuvant polychemotherapy (NAPCT); targeted therapy drugs were simultaneously added to taxane-containing regimens in 2 patients with HER2-positive tumors. Results. The mean age of the patients was 44.3Β±13.8 years, which was substantially younger than that of the total population of BC patients. The histological pattern of tumor nodules in both mammary glands was the same in 11 patients and the tumors in the mammary glands were different in 3 patients. Therapeutic pathomorphism (TP) was absent in 2 (8.3%) cases; it was poorly expressed (grade 1) in 4 (12.5%) cases, grades 2, 3, and 4 were seen in 7 (29.2%), 6 (16.7%), and 9 (33.3%), respectively. None of the 7 patients with the edematous-infiltrative form of BC achieved grade 4 TP despite its different biological types. The immunohistochemical study showed that edematous infiltrative BC was presented as a luminal type in 5 cases, as a triple-negative one in 1 case, and as a luminal type B, HER2-positive in 1 case. Nine of the 28 cases achieved complete TP in the primary tumor, but only one patient had it in both tumors with different biological types. Conclusion. In most cases, the reaction of synchronous tumors to NAPCT did not coincide in the same patient. A complete pathomorphism was most common in the triple negative type (33.3Β±16.6%), which corresponds to the current ideas on the behavior of this aggressive biological type of BC. The authors consider it necessary to further study the reaction of synchronous tumors to neoadjuvant therapy and to accumulate clinical materials for the reliable confirmation of the findings, which is important for the development of an adequate treatment policy and theoretical knowledge of the pathogenesis of drug sensitivity/resistance of breast tumors.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΡΠ΅Π½ΠΈΡΡ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎ-ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π΄Π²ΡΡΡΠΎΡΠΎΠ½Π½Π΅Π³ΠΎ ΡΠΈΠ½Ρ
ΡΠΎΠ½Π½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΡΡ
ΠΆΠ΅Π»Π΅Π· (Π ΠΠ) ΠΊ Π½Π΅ΠΎΠ°Π΄ΡΡΠ²Π°Π½ΡΠ½ΠΎΠΉ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠΈΠ»ΠΈ 14 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎ-ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌ ΡΠΈΠ½Ρ
ΡΠΎΠ½Π½ΡΠΌ Π ΠΠ, ΠΊΠΎΡΠΎΡΡΠ΅ Π½Π° I ΡΡΠ°ΠΏΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠΎΠ»ΡΡΠΈΠ»ΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅. Π£ 11 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΡ 6 Π΄ΠΎ 8 ΠΊΡΡΡΠΎΠ² Π½Π΅ΠΎΠ°Π΄ΡΡΠ²Π°Π½ΡΠ½ΠΎΠΉ ΠΏΠΎΠ»ΠΈΡ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ (ΠΠΠΠ₯Π’), Ρ 2 Ρ ΠER2-ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠΌΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΡΠΌΠΈ ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ ΠΊ ΡΠ°ΠΊΡΠ°Π½ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΠΌ ΡΠ΅ΠΆΠΈΠΌΠ°ΠΌ Π΄ΠΎΠ±Π°Π²Π»ΡΠ»ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΡΠ°ΡΠ³Π΅ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π‘ΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠΎΡΡΠ°Π²ΠΈΠ» 44,3Β±13,8 Π³ΠΎΠ΄Π°, ΡΡΠΎ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΠΌΠ΅Π½ΡΡΠ΅ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΎΠ±ΡΠ΅ΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠ΅ΠΉ Π±ΠΎΠ»ΡΠ½ΡΡ
Π ΠΠ. ΠΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΎΡΠΌΠ° ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΡΠ·Π»ΠΎΠ² Ρ 11 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Π±ΡΠ»Π° ΠΎΠ΄ΠΈΠ½Π°ΠΊΠΎΠ²ΠΎΠΉ Π² ΠΎΠ±Π΅ΠΈΡ
ΠΌΠΎΠ»ΠΎΡΠ½ΡΡ
ΠΆΠ΅Π»Π΅Π·Π°Ρ
, Ρ 3 ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π² ΠΌΠΎΠ»ΠΎΡΠ½ΡΡ
ΠΆΠ΅Π»Π΅Π·Π°Ρ
ΠΎΡΠ»ΠΈΡΠ°Π»ΠΈΡΡ. ΠΠ΅ΡΠ΅Π±Π½ΡΠΉ ΠΏΠ°ΡΠΎΠΌΠΎΡΡΠΎΠ· (ΠΠ) ΠΎΡΡΡΡΡΡΠ²ΠΎΠ²Π°Π» Π² 2 (8,3%) ΡΠ»ΡΡΠ°ΡΡ
, Π±ΡΠ» ΡΠ»Π°Π±ΠΎ Π²ΡΡΠ°ΠΆΠ΅Π½ (I ΡΡΠ΅ΠΏΠ΅Π½Ρ) Π² 4 (12,5%), II ΡΡΠ΅ΠΏΠ΅Π½Ρ Π±ΡΠ»Π° Π² 7 (29,2%), III ΡΡΠ΅ΠΏΠ΅Π½Ρ β Π² 6 (16,7%), IV ΡΡΠ΅ΠΏΠ΅Π½Ρ β Π² 9 (33,3%) ΡΠ»ΡΡΠ°ΡΡ
. ΠΠ· 7 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΎΡΠ΅ΡΠ½ΠΎ-ΠΈΠ½ΡΠΈΠ»ΡΡΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠΎΡΠΌΠΎΠΉ Π ΠΠ Π½ΠΈ Ρ ΠΎΠ΄Π½ΠΎΠΉ Π½Π΅ Π±ΡΠ» Π΄ΠΎΡΡΠΈΠ³Π½ΡΡ ΠΠ IV ΡΡΠ΅ΠΏΠ΅Π½ΠΈ, Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° Π΅Π³ΠΎ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠΈΠΏΡ. ΠΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠΠ₯-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΎΡΠ΅ΡΠ½ΠΎ-ΠΈΠ½ΡΠΈΠ»ΡΡΡΠ°ΡΠΈΠ²Π½ΡΠΉ Π ΠΠ Π² 5 ΡΠ»ΡΡΠ°ΡΡ
Π±ΡΠ» ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠΌ ΡΠΈΠΏΠΎΠΌ, Π² 1 ΡΠ»ΡΡΠ°Π΅ β ΡΡΠΎΠΉΠ½ΡΠΌ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΡΠΌ ΠΈ Π² 1 β Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠΌ ΡΠΈΠΏΠΎΠΌ Π, HER2-ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠΌ. ΠΠΎΠ»Π½ΡΠΉ ΠΠ Π² ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π±ΡΠ» Π΄ΠΎΡΡΠΈΠ³Π½ΡΡ Π² 9 ΠΈΠ· 28 ΡΠ»ΡΡΠ°Π΅Π², Π½ΠΎ Π»ΠΈΡΡ Ρ ΠΎΠ΄Π½ΠΎΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Π² ΠΎΠ±Π΅ΠΈΡ
ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠΈΠΏΠ°ΠΌΠΈ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π Π΅Π°ΠΊΡΠΈΡ ΡΠΈΠ½Ρ
ΡΠΎΠ½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Ρ ΠΎΠ΄Π½ΠΎΠΉ ΠΈ ΡΠΎΠΉ ΠΆΠ΅ Π±ΠΎΠ»ΡΠ½ΠΎΠΉ Π½Π° ΠΠΠΠ₯Π’ Π² Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΡΠ»ΡΡΠ°Π΅Π² Π½Π΅ ΡΠΎΠ²ΠΏΠ°Π΄Π°Π»Π°. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ ΠΏΠΎΠ»Π½ΡΠΉ ΠΏΠ°ΡΠΎΠΌΠΎΡΡΠΎΠ· ΠΎΡΠΌΠ΅ΡΠ΅Π½ ΠΏΡΠΈ ΡΡΠΎΠΉΠ½ΠΎΠΌ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠΌ ΡΠΈΠΏΠ΅ (33,3Β±16,6%), ΡΡΠΎ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠΌ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡΠΌ ΠΎ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΡΡΠΎΠ³ΠΎ Π°Π³ΡΠ΅ΡΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠΏΠ° Π ΠΠ. ΠΡ ΠΏΠΎΠ»Π°Π³Π°Π΅ΠΌ, ΡΡΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ ΡΠΈΠ½Ρ
ΡΠΎΠ½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Π½Π° Π½Π΅ΠΎΠ°Π΄ΡΡΠ²Π°Π½ΡΠ½ΠΎΠ΅ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅, Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° Π΄Π»Ρ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΈΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
, ΡΡΠΎ Π²Π°ΠΆΠ½ΠΎ Π΄Π»Ρ Π²ΡΡΠ°Π±ΠΎΡΠΊΠΈ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠΉ ΡΠ°ΠΊΡΠΈΠΊΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ Π½Π°ΡΠ°Π±ΠΎΡΠΊΠΈ ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π½Π°Π½ΠΈΠΉ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π° Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ/ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ
Π€ΠΠΠ―Π ΠΠΠ ΠΠΠΠΠ§ΠΠΠ ΠΠΠΠΠΠ«. ΠΠΠΠΠΠΠΠ‘ΠΠΠ― ΠΠ£Π§ΠΠΠΠ― ΠΠΠΠΠΠΠ‘Π’ΠΠΠ Π ΠΠΠ§ΠΠΠΠ
F ilariasis is a tropical disease caused by the parasite Dirofilaria repens. The lesion of the breast occurs in 10%. Purpose. To present a clinical case of a woman with breast pathology. Materials and methods. The condition did not manifest clinically. Detection of atypical cyst in the breast using ultrasound technology and its subsequent biopsy allowed to confirm the pathology. Results. The possibilities of an integrated approach in the diagnosis of breast lesions and minimally invasive treatment of a patient with a parasitic lesion of the breast are demonstrated.Π€ ΠΈΠ»ΡΡΠΈΠΎΠ· - ΡΡΠΎ ΡΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅, Π²ΡΠ·Π²Π°Π½Π½ΠΎΠ΅ ΠΏΠ°ΡΠ°Π·ΠΈΡΠΎΠΌ Dirofilaria repens. ΠΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ Π²ΡΡΡΠ΅ΡΠ°Π΅ΡΡΡ Π² 10%. Π¦Π΅Π»Ρ. ΠΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ ΠΆΠ΅Π½ΡΠΈΠ½Ρ Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅ ΠΏΡΠΎΡΠ²Π»ΡΠ»ΠΎΡΡ. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π°ΡΠΈΠΏΠΈΡΠ½ΠΎΠΉ ΠΊΠΈΡΡΡ Π² ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Π΅ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ°Ρ Π΅Π΅ Π±ΠΈΠΎΠΏΡΠΈΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΈ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠ΄ΠΈΡΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π½Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π° Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠΉ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΈ ΠΌΠ°Π»ΠΎΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Ρ ΠΏΠ°ΡΠ°Π·ΠΈΡΠ°ΡΠ½ΡΠΌ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ
Breast filariasis. Complex diagnostic and treatment [Π€ΠΠΠ―Π ΠΠΠ ΠΠΠΠΠ§ΠΠΠ ΠΠΠΠΠΠ«. ΠΠΠΠΠΠΠΠ‘ΠΠΠ― ΠΠ£Π§ΠΠΠΠ― ΠΠΠΠΠΠΠ‘Π’ΠΠΠ Π ΠΠΠ§ΠΠΠΠ]
Filariasis is a tropical disease caused by the parasite Dirofilaria repens. The lesion of the breast occurs in 10%. Purpose. To present a clinical case of a woman with breast pathology. Materials and methods. The condition did not manifest clinically. Detection of atypical cyst in the breast using ultrasound technology and its subsequent biopsy allowed to confirm the pathology. Results. The possibilities of an integrated approach in the diagnosis of breast lesions and minimally invasive treatment of a patient with a parasitic lesion of the breast are demonstrated. Β© 2019 Russian Electronic Journal of Radiology. All rights reserved
New procedures for determining resection margins during organ-sparing surgery in patients with breast cancer
Breast cancer (BC) occupies a leading place in the structure of cancers among the female population worldwide. The number of breast cancer patients currently tends to increase in the 30β45-year-old group. Organ-sparing treatment (OST) is recommended to improve quality of life in the patients. The operation involves the excision of a segment with a breast lump, but achievement of negative resection margins is mandatory. The latest data show that to achieve the purity of resection margins, indents of up to 2 mm and 1 mm are currently recommended for ductal carcinoma in situ and an invasive form, respectively. Despite the existing data on the safety and benefits of OST, 20 to 30% of patients with invasive or non-invasive BC usually undergo a reoperation. The increased number of repeated resections, and especially mastectomies, leads to severe psychological and physical traumas in women, substantially worsening the quality of life. It is important to correctly mark resection margins during surgery. The paper presents up-to-date methods to examine resection margins intraoperatively. It includes techniques, such as micro-CT, Cherenkov luminescence imaging, radiofrequency spectroscopy-based βMargin Probeβ, and fluorescence imaging. The use of the most promising techniques and their long-term results are described. Β© A group of authors, 2020
Treatment options of breast cancer patients after breast-conserving surgery with positive margins R1
Introduction: in organ-preserving operations for breast cancer, the risk of recurrence is associated with many factors, including positive resection margins. The article presents data from the literature, which considers the risk of relapse depending on the positive, close and negative edges of resection. The purpose of this study was to increase the effectiveness of treatment of breast cancer patients after organ-preserving operations with positive resection edges. Materials and methods: the study included 1219 patients with breast cancer who underwent organ-preserving and oncoplastic resections of the breast. Urgent cytological and histological intraoperative examination of the resection edges is analyzed in detail, and the marking of the resection edges is presented. The clinical and morphological characteristics of patients with breast cancer at R0 and Rl are presented. Results: positive edge of Rl resection was diagnosed in 53 cases, which was 4,3Β±2,8%, in oncoplastic resections in 4,1Β±1,1%, in classical breast resections in 4,6Β±0,7% (p>0,05). In the group of patients with Rl, multicentricity of the tumor was diagnosed in 11,1Β±5,3%, and monocentric tumor was detected in 4,1 Β±0,5%. Further tactics in the case of Rl detection were as follows: in 21 cases, radiation therapy was performed on the breast, in 32 cases, re - operation: resection of the edges - in 14 patients, radical mastectomy - in 9 patients, subcutaneous mastectomy with simultaneous reconstruction with autologous flaps or endoprostheses - in 9 patients. In the group of patients with re-operation, 43,7% of the planned study showed no signs of malignancy, 56,3% showed a residual tumor, while 31.3% were diagnosed with cancer in situ. So in the case of resection of the edges in 5 cases, a residual tumor was diagnosed in the resected edges, which was 35,7%, and in the case of mastectomy, a residual tumor was detected in 68,4%. Re-operation in R1 after oncoplastic resections was performed in 71,4%, and in classical resections in 56,4%, which correlates with the literature data. Conclusion: in two groups of patients after organ-preserving operations with positive resection margins, no local recurrence was detected during the follow-up period from 1 to 60 months, and distant metastases, namely, lesions of the bones of the skeleton, were diagnosed in 2 patients. Thus, with a positive edge of resection after organ-preserving surgery, both surgical treatment and radiation therapy can be performed. Although the presence of a tumor in the colored edges of resection is clearly associated with a high frequency of local relapses, but the relapse is also influenced by the biological characteristics of the tumor and the body. Individual characteristics are the basis of tumor biology, and the extent of their influence on long-term results is not reduced due to the wide surgical margins of resection. Β© 2020 Izdatel'stvo Meditsina. All rights reserved
LAPAROSCOPIC RESECTION OF THE HORSESHOE KIDNEY FOR RENAL CELL CARCINOMA
Renal fusion is one of the most common kidney anomalies. The most frequent is horseshoe kidney, characterized by a fusion of the poles (typically the lower poles) of the kidneys. We described a clinical case of a malignant tumor in the right half of the horseshoe kidney (stage 1 cancer, CT1aN0M0) in a man aged 65 years, who underwent laparoscopic resection. It was shown that laparoscopy is no less efficient than open surgery. However, in planning the operation, it is necessary to use spiral computed tomography for three-dimensional reconstruction of the organ and identification of its anatomical features caused by aberrant blood supply to horseshoe kidney
ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠ³ΠΎ ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠ³ΠΎ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ
Objective - to analyze the clinical and pathomorphological characteristics of types A and B mucinous breast cancer (BC) and micropapillary carcinoma with obvious mucus production. Subject and methods. The paper analyzes the results of examination and treatment in 38 patients. Early-stage (I and IIA) BC was diagnosed in 81.6% of cases in the study. The patientsβ mean age was 60.2Β±7.9 years (range 33-78). The distribution of the patients according to the stages of BC was as follows: 18 (47.4%) patients with Stage I BC, 13 (34.2%) with IIA stage, 3 (7.9%) with IIB stage, 2 (5.3%) with IIIA stage, 1 (2.6%) with IIIB stage, 1 (2.6%) with IIIC stage. The lymph node status was pNin 33 cases with no lymph node metastases in mucinous BC and pNin 5 cases with invasive micropapillary carcinoma (IMPC) of the breast. The multicentricity of tumor nodules was diagnosed in 4 (10.5%) cases; the number of tumor nodules was from 2 to 3 in the breast, as well as in all cases in mucinous BC. The distribution of the patients according to the molecular biological type of a tumor was as follows: luminal A tumor in 21 (58.3%) cases, luminal B Her2-negative cancer in 11 (30.5%), luminal B Her2-positive tumor in 3 (8, 3%), and triple negative BC in 1 (2.9%). There was a triple negative BC type in 1 case of IMPC of the breast, a luminal B Her2-positive type in 3 cases of mucinous BC, and luminal types of the tumor were diagnosed in the other cases. Results. Lymph node metastases were found in 5 (13.2%) cases. In this investigation, all the patients with lymph node metastases had one type of cancer - invasive mucinous micropapillary carcinoma. At the same time, mucinous micropapillary carcinoma was confirmed by biopsy only in 1 female patient. During the follow-up, 38 patients with mucinous and mucinous micropapillary BC were found to have distant metastases in none of the groups. The investigation revealed the following relationship of lymph node metastatic spread: the metastases were diagnosed as T1 in 10% of cases, T2 in 15.4%, and T3 in 25%. Conclusion. The task of a pathologist is to identify and correctly differentiate invasive micropapillary carcinoma with obvious mucus production from simple mucinous carcinomas types A and B in the preoperative period of the examination. So, only a study of sentinel lymph nodes can be performed in only simple mucinous breast carcinoma; axillary lymphadenectomy should be carried out in micropapillary carcinoma with obvious mucus production. Treatment policy for invasive micropapillary BC with obvious mucus production should be more aggressive, while that for mucinous cancer is minimal.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ - ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΏΠ°ΡΠΎΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ (Π ΠΠ) ΡΠΈΠΏΠ° Π ΠΈ Π ΠΈ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΡΠ»ΠΈΠ·Π΅ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ 38 Π±ΠΎΠ»ΡΠ½ΡΡ
. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π² 81,6% ΡΠ»ΡΡΠ°Π΅Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Ρ Π½Π°ΡΠ°Π»ΡΠ½ΡΠ΅ (I ΠΈ IIΠ) ΡΡΠ°Π΄ΠΈΠΈ Π ΠΠ. Π‘ΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ 60,2Β±7,9 Π³ΠΎΠ΄Π° (33-78 Π»Π΅Ρ). Π Π°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΠΎ ΡΡΠ°Π΄ΠΈΡΠΌΠΈ Π ΠΠ: I - 18 (47,4%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ, IIA - 13 (34,2%), IIB - 3 (7,9%), IIIA - 2 (5,3%), IIIB - 1 (2,6%), IIIΠ‘ - 1 (2,6%). Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ²: ΡN0 - 33 ΡΠ»ΡΡΠ°Ρ, ΠΏΡΠΈ ΡΡΠΎΠΌ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Ρ ΠΎΡΡΡΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ Π² Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»Π°Ρ
ΠΏΡΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΌ Π ΠΠ, ΡN1-3 - 5 ΡΠ»ΡΡΠ°Π΅Π² ΠΏΡΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ΅ (ΠΠΠΠ) Π ΠΠ. ΠΡΠ»ΡΡΠΈΡΠ΅Π½ΡΡΠΈΡΠ½ΠΎΡΡΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΡΠ·Π»ΠΎΠ² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Π° Π² 4 (10,5%) ΡΠ»ΡΡΠ°ΡΡ
, ΡΠΈΡΠ»ΠΎ ΡΠ·Π»ΠΎΠ² Π² ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Π΅ ΠΎΡ 2 Π΄ΠΎ 3 ΠΈ Π²ΠΎ Π²ΡΠ΅Ρ
ΡΠ»ΡΡΠ°ΡΡ
ΠΏΡΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΌ Π ΠΠ. Π Π°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠΏΠ° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΡΠ»Π΅Π΄ΡΡΡΠ΅Π΅: Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠΉ ΡΠΈΠΏ Π Π² 21 (58,3%) ΡΠ»ΡΡΠ°Π΅, Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠΉ ΡΠΈΠΏ Π Her2-Π½Π΅Π³Π°ΡΠΈΠ²Π½ΡΠΉ Π² 11 (30,5%), Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠΉ ΡΠΈΠΏ Π Her2-ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠΉ Π² 3 (8,3%), ΡΡΠΎΠΉΠ½ΠΎΠΉ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΡΠΉ ΡΠΈΠΏ Π² 1 (2,9%). ΠΡΠΈ ΠΠΠΠ Π ΠΠ Π² 1 ΡΠ»ΡΡΠ°Π΅ Π²ΡΡΠ²Π»Π΅Π½ ΡΡΠΎΠΉΠ½ΠΎΠΉ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΡΠΉ ΡΠΈΠΏ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ, Π° ΠΏΡΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΌ Π ΠΠ Π² 3 ΡΠ»ΡΡΠ°ΡΡ
- Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠΉ ΡΠΈΠΏ Π ΠΠ΅r2-ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠΉ, Π² ΠΎΡΡΠ°Π»ΡΠ½ΡΡ
ΡΠ»ΡΡΠ°ΡΡ
Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Ρ Π»ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΠ΅ ΡΠΈΠΏΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ΅ΡΠ°ΡΡΠ°Π·Ρ Π² Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»Π°Ρ
ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Ρ Π² 5 (13,2%) ΡΠ»ΡΡΠ°ΡΡ
. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π²ΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Ρ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Π°ΠΌΠΈ Π² Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»Π°Ρ
ΠΈΠΌΠ΅Π»ΠΈ ΠΎΠ΄ΠΈΠ½ ΡΠΈΠΏ ΡΠ°ΠΊΠ° - ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ ΠΌΡΡΠΈΠ½ΠΎΠ·Π½ΡΡ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΡΡ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ. ΠΡΠΈ ΡΡΠΎΠΌ ΡΠΎΠ»ΡΠΊΠΎ Ρ 1 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ Π±ΠΈΠΎΠΏΡΠΈΠΈ Π±ΡΠ»Π° ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π° ΠΌΡΡΠΈΠ½ΠΎΠ·Π½Π°Ρ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½Π°Ρ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ°. ΠΠ° ΠΏΠ΅ΡΠΈΠΎΠ΄ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ Ρ 38 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ ΡΠΎ ΡΠ»ΠΈΠ·ΠΈΡΡΡΠΌ ΠΈ ΠΌΡΡΠΈΠ½ΠΎΠ·Π½ΡΠΌ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΡΠΌ Π ΠΠ ΠΎΡΠ΄Π°Π»Π΅Π½Π½ΡΡ
ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ² Π½Π΅ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΎ Π½ΠΈ Π² ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π³ΡΡΠΏΠΏ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π²ΡΡΠ²Π»Π΅Π½Π° ΡΠ»Π΅Π΄ΡΡΡΠ°Ρ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π² Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»Π°Ρ
: ΠΏΡΠΈ T1 Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Ρ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·Ρ Π² 10% ΡΠ»ΡΡΠ°Π΅Π², ΠΏΡΠΈ T2 - Π² 15,4%, ΠΏΡΠΈ T3 - Π² 25%. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ°Π΄Π°ΡΠ° Π²ΡΠ°ΡΠ°-ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΎΠ°Π½Π°ΡΠΎΠΌΠ° - Π²ΡΡΠ²ΠΈΡΡ ΠΈ ΠΏΡΠ°Π²ΠΈΠ»ΡΠ½ΠΎ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°ΡΡ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΡΡ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΡΠ»ΠΈΠ·Π΅ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΎΡ ΠΏΡΠΎΡΡΡΡ
ΠΌΡΡΠΈΠ½ΠΎΠ·Π½ΡΡ
ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌ ΡΠΈΠΏΠ° A ΠΈ B Π² ΠΏΡΠ΅Π΄ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π’Π°ΠΊ, Π² ΡΠ»ΡΡΠ°Π΅ ΡΠΎΠ»ΡΠΊΠΎ ΠΏΡΠΎΡΡΠΎΠΉ ΠΌΡΡΠΈΠ½ΠΎΠ·Π½ΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΌΠΎΠΆΠ½ΠΎ Π²ΡΠΏΠΎΠ»Π½ΡΡΡ ΡΠΎΠ»ΡΠΊΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΠ³Π½Π°Π»ΡΠ½ΡΡ
Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ², Π° ΠΏΡΠΈ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΠΎΠΌ ΡΠ°ΠΊΠ΅ Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΡΠ»ΠΈΠ·Π΅ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΡ ΠΏΠΎΠ΄ΠΌΡΡΠ΅ΡΠ½ΡΡ Π»ΠΈΠΌΡΠ°Π΄Π΅Π½ΡΠΊΡΠΎΠΌΠΈΡ. ΠΠ΅ΡΠ΅Π±Π½Π°Ρ ΡΠ°ΠΊΡΠΈΠΊΠ° ΠΏΡΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΌ ΠΌΠΈΠΊΡΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡΠ½ΠΎΠΌ ΡΠ°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΡΠ»ΠΈΠ·Π΅ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π΄ΠΎΠ»ΠΆΠ½Π° Π±ΡΡΡ Π±ΠΎΠ»Π΅Π΅ Π°Π³ΡΠ΅ΡΡΠΈΠ²Π½ΠΎΠΉ, ΡΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ ΠΏΡΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΌ ΡΠ°ΠΊΠ΅ ΠΎΠ½Π° ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½Π°